Status:
COMPLETED
Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Diabetes Mellitus
Eligibility:
MALE
20-45 years
Phase:
PHASE1
Brief Summary
A study evaluating the safety and pharmacokinetics of multiple oral doses of an investigational oral diabetic agent when given to healthy Japanese male volunteers.
Eligibility Criteria
Inclusion
- Men, aged 20 to 45 years, inclusive
- Body mass index in the range of 17.6 to 26.4 kg/m2
- Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram (ECG)
Exclusion
- History of cardiac, thyroid, muscle, and kidney abnormalities
- History of NSAID induced bronchospasm or asthma
- History of any clinically important allergies
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
End Date :
March 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00448032
Start Date
November 1 2006
End Date
March 1 2007
Last Update
December 5 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tokyo, Japan, 171-0014